Showing results (81-90 of 1,846) with videos related to
Sort By:
Pageof 185
Journal of Child and Adolescent Psychopharmacology|September 4, 2019
Probiotics for Gastrointestinal Symptoms and Quality of Life in Autism: A Placebo-Controlled Pilot TrialL Eugene Arnold, Ruth Ann Luna, Kent Williams, et al.Journal of Child and Adolescent Psychopharmacology|October 25, 2022
Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or SchizophreniaTodd Riccobene, Robert Riesenberg, Paul P Yeung, et al.Journal of Child and Adolescent Psychopharmacology|July 19, 2016
Pharmacokinetics and Tolerability of Single-Ascending Doses of Desvenlafaxine Administered to Children and Adolescents with Major Depressive DisorderRobert L Findling, James Groark, Karen A Tourian, et al.Journal of Child and Adolescent Psychopharmacology|April 28, 2021
Looking for the Good Timing: Predictors of Length of Stay and Therapeutic Outcomes in Adolescent Inpatients with Severe or Treatment-Refractory Mood DisordersXavier Benarous, Cora Cravero, Barbara Jakubowicz, et al.Journal of Child and Adolescent Psychopharmacology|June 20, 2015
Vitamin D3 Supplemental Treatment for Mania in Youth with Bipolar Spectrum DisordersElif M Sikoglu, Ana A Liso Navarro, Debra Starr, et al.Journal of Child and Adolescent Psychopharmacology|May 16, 2015
Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorderGraham J Emslie, Thomas G Wells, Apurva Prakash, et al.Journal of Child and Adolescent Psychopharmacology|July 2, 2015
The Effectiveness and Safety of Antipsychotic and Antidepressant Medications in Individuals with 22q11.2 Deletion SyndromeNetta Dori, Tamar Green, Abraham Weizman, et al.Journal of Child and Adolescent Psychopharmacology|November 11, 2022
Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part III-Treatment and Prevention of InfectionsMichael S Cooperstock, Susan E Swedo, Mark S Pasternack, et al.Journal of Child and Adolescent Psychopharmacology|September 9, 2006
Risperidone in the management of disruptive behavior disordersGahan J Pandina, Michael G Aman, Robert L FindlingJournal of Child and Adolescent Psychopharmacology|September 9, 2006
An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in TaiwanSusan Shur-Fen Gau, Hsin-Yi Shen, Wei-Tusen Soong, et al.Pageof 185